Staar Surgical stock had its Relative Strength (RS) Rating upgraded from 77 to 87 Thursday.
This proprietary rating tracks technical performance by using a 1 (worst) to 99 (best) score that identifies how a stock's price performance over the last 52 weeks matches up against the rest of the market.
Decades of market research shows that the top-performing stocks typically have an RS Rating north of 80 in the early stages of their moves.
Looking For The Best Stocks To Buy And Watch? Start Here
Is Star Surgical Stock A Buy?
Staar Surgical reclaimed its 50-day moving average and is building a consolidation with a 52.68 buy point. See if the medical stock can clear the breakout price in volume at least 40% above average.
The lens maker showed 0% EPS growth in its most recent report, while sales growth came in at 5%.
Staar Surgical stock earns the No. 20 rank among its peers in the Medical-Products industry group. LeMaitre Vascular, Globus Medical and Boston Scientific are among the top 5 highly rated stocks within the group.
